The original sins of clinical trials with intravenous immunoglobulins in sepsis

Intravenous immunoglobulins (IVIGs) have not yet demonstrated robust evidence in the benefit for treatment of sepsis. In spite of multiple clinical trials performed with IVIG in sepsis, it remains an experimental therapy for this severe condition. Nonetheless, these trials do not address a number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Almansa, Raquel, Tamayo, Eduardo, Andaluz-Ojeda, David, Nogales, Leonor, Blanco, Jesús, Eiros, Jose Maria, Gomez-Herreras, Jose Ignacio, Bermejo-Martin, Jesus F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343266/
https://www.ncbi.nlm.nih.gov/pubmed/25882822
http://dx.doi.org/10.1186/s13054-015-0793-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343266/
https://www.ncbi.nlm.nih.gov/pubmed/25882822
http://dx.doi.org/10.1186/s13054-015-0793-0

Ejemplares similares